Business Context and Reporting Period
Company: Newmark Group, Inc. (NMRK)
Filing Type: Form 8-K (Current Report)
Date of Report: October 30, 2025
Reporting Period: Third quarter ended September 30, 2025
This filing announces the Company's financial results for the quarter ended September 30, 2025, via a press release attached as Exhibit 99.1. It also notifies shareholders of a change to the date of the 2025 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release (Exhibit 99.1) referenced in Item 2.02 but are not detailed in the body of this Form 8-K.
Material Changes
- Annual Meeting Date Change: The Board of Directors has rescheduled the 2025 Annual Meeting of Stockholders to December 30, 2025.
- Proposal Deadlines: Due to the new meeting date, the deadline for stockholder proposals under Rule 14a-8 and advance notice proposals under the Company's bylaws is now November 9, 2025.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes a standard disclaimer regarding forward-looking statements found in the attached press release. These statements involve risks and uncertainties that could cause actual results to differ materially from expectations. The Company undertakes no obligation to update these statements except as required by law.
Risks: Investors are directed to the Company's SEC filings (10-K, 10-Q, 8-K) for a detailed discussion of risk factors and the Special Note on Forward-Looking Information.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2025 financial results, including revenue, net income, and cash flow figures.
- Verify the new deadline of November 9, 2025, for submitting stockholder proposals for the 2025 Annual Meeting.
- Confirm the exact time and location of the Annual Meeting once the Notice of 2025 Annual Meeting and proxy statement are issued.
- Check subsequent filings for any updates to risk factors or forward-looking guidance.